Ferrara G, Petrillo MG, Giani T, Marrani E, Filippeschi C, Oranges T, et al. Clinical use and molecular action of corticosteroids in the pediatric age. Int J Mol Sci. 2019;20(2):444

Parker B, Bruce I. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus. Lupus. 2007;16:387–93.

CAS  PubMed  Google Scholar 

Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021;56:489–526.

PubMed  PubMed Central  Google Scholar 

Cutler CS, Koreth J, Ritz J. Mechanistic approaches for the prevention and treatment of chronic GVHD. Blood. 2017;129:22–9.

CAS  PubMed  PubMed Central  Google Scholar 

Ottinger HD, Ferencik S, Beelen DW, Lindemann M, Peceny R, Elmaagacli AH, et al. Hematopoietic stem cell transplantation: Contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood. 2003;102:1131–7.

CAS  PubMed  Google Scholar 

Derijks LJJ, Wong DR, Hommes DW, van Bodegraven AA. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of inflammatory Bowel disease. Clin Pharmacokinet. 2018;57:1075–106.

Jeon HH, Lee HJ, Jang HW, Yoon JY, Jung YS, Park SJ, et al. Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis. World J Gastroenterol. 2013;19:265–73.

CAS  PubMed  PubMed Central  Google Scholar 

McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20:131–7.

PubMed  Google Scholar 

Göknar N, Webb H, Waters A, Tullus K. Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses? Pediatr Nephrol. 2022;37:1575–84.

PubMed  Google Scholar 

Bloechliger M, Reinau D, Spoendlin J, Chang SC, Kuhlbusch K, Heaney LG, et al. Adverse events profile of oral corticosteroids among asthma patients in the UK: Cohort study with a nested case-control analysis. Respir Res. 2018;19:75.

Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion CNS Disord. J Clin Psychiatry. 2001;3:17–21.

Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44:61–98.

CAS  PubMed  Google Scholar 

Hofer KN. Oral budesonide in the management of Crohn’s disease. Ann Pharmacother. 2003;37:1457–64.

CAS  PubMed  Google Scholar 

Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK531462/. Accessed 24 Jun 2024.

Meduri GU, Annane D, Confalonieri M, Chrousos GP, Rochwerg B, Busby A, et al. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Intensive Care Med. 2020;46:2284–96.

CAS  PubMed  PubMed Central  Google Scholar 

Sæves I, Line P-D, Bergan S. The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation. Ther Drug Monit. 2012;34:452–9.

PubMed  Google Scholar 

Barraclough KA, Isbel NM, McWhinney BC, Ungerer JPJ, Medley G, Johnson DW, et al. Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. Eur J Clin Pharmacol. 2011;67:1243–52.

CAS  PubMed  Google Scholar 

Magee MH, Blum RA, Lates CD, Jusko WJ. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol. 2001;41:1180–94.

CAS  PubMed  PubMed Central  Google Scholar 

Potter JM, McWhinney BC, Sampson L, Hickman PE. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monit. 2004;26:408–14.

CAS  PubMed  Google Scholar 

Hill MR, Szefler SJ, Ball BD, Bartoszek M, Brenner AM. Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther. 1990;48:390–8.

CAS  PubMed  Google Scholar 

Gatti G, Perucca E, Frigo GM, Notarangelo LD, Barberis L, Martini A. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission. Br J Clin Pharmacol. 1984;17:423–31.

CAS  PubMed  PubMed Central  Google Scholar 

Miller PF, Bowmer CJ, Wheeldon J, Brocklebank JT. Pharmacokinetics of prednisolone in children with nephrosis. Arch Dis Child. 1990;65:196–200.

CAS  PubMed  PubMed Central  Google Scholar 

Milsap RL, George DE, Szefler SJ, Murray KA, Lebenthal E, Jusko WJ. Effect of inflammatory bowel disease on absorption and disposition of prednisolone. Dig Dis Sci. 1983;28:161–8.

CAS  PubMed  Google Scholar 

Frey FJ, Frey BM. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome. Am J Kidney Dis. 1984;3:339–48.

CAS  PubMed  Google Scholar 

Kong AN, Ludwig EA, Slaughter RL, DiStefano PM, DeMasi J, Middleton E, et al. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther. 1989;46:616–28.

CAS  PubMed  Google Scholar 

Meibohm B, Derendorf H, Möllmann H, Fröhlich P, Tromm A, Wagner M, et al. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids. Int J Clin Pharmacol Ther. 1999;37:367–76.

CAS  PubMed  Google Scholar 

Magee MH, Blum RA, Lates CD, Jusko WJ. Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation. Br J Clin Pharmacol. 2002;53:474–84.

CAS  PubMed  PubMed Central  Google Scholar 

Briggs WA, Gimenez LF, Samaniego-Picota M, Choi MJ, Nadasdy T, Eustace J, et al. Relationship between lymphocyte and clinical steroid responsiveness in focal segmental glomerulosclerosis. J Clin Pharmacol. 2000;40:115–23.

CAS  PubMed  Google Scholar 

Tornatore KM, Logue G, Venuto RC, Davis PJ. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males. J Clin Pharmacol. 1997;37:304–11.

CAS  PubMed  Google Scholar 

Barraclough KA, Staatz CE, Johnson DW, Lee KJ, McWhinney BC, Ungerer JPJ, et al. Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week. Transpl Int. 2012;25:1182–93.

CAS  PubMed  Google Scholar 

Kawedia JD, Liu C, Pei D, Cheng C, Fernandez CA, Howard SC, et al. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood. 2012;119:1658–64.

CAS  PubMed  PubMed Central  Google Scholar 

Abd Rahman AN, Tett SE, Staatz CE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clin Pharmacokinet. 2013;52:303–31.

CAS  PubMed  Google Scholar 

Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43:623–53.

CAS  PubMed  Google Scholar 

Bartelink IH, Lalmohamed A, van Reij EML, Dvorak CC, Savic RM, Zwaveling J, et al. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. Lancet Haematol. 2016;3:e526–36.

PubMed  PubMed Central  Google Scholar 

Admiraal R, Nierkens S, de Witte MA, Petersen EJ, Fleurke GJ, Verrest L, et al. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis. Lancet Haematol. 2017;4:e183–91.

PubMed  Google Scholar 

Dekker L, Calkoen FG, Jiang Y, Blok H, Veldkamp SR, De Koning C, et al. Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia. Blood Adv. 2022;6:1969–76.

CAS  PubMed  PubMed Central  Google Scholar 

Admiraal R, van Kesteren C, Jol-van der Zijde CM, van Tol MJD, Bartelink IH, Bredius RGM, et al. Population pharmacokinetic modeling of thymoglobulin® in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing. Clin Pharmacokinet. 2015;54:435–46.

CAS  PubMed  Google Scholar 

Langenhorst JB, van Kesteren C, van Maarseveen EM, Dorlo TPC, Nierkens S, Lindemans CA, et al. Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes. Blood Adv. 2019;3:2179–87.

CAS  PubMed  PubMed Central  Google Scholar 

Skauby RH, Bjerre A, Sæves I, Vethe NT, Bremer S, Svarstad A, et al. Prednisolone and prednisone pharmacokinetics in pediatric renal transplant recipients—a prospective study. Ther Drug Monit. 2017;39:472–82.

CAS  PubMed